Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click ...
On July 1, 2026, Vertex Pharmaceuticals announced that the FDA approved an expanded indication for CASGEVY (exagamglogene autotemcel) to ...
Creating data products is a good way to accelerate delivery, reuse data assets, reduce risks, and manage costs. Standardized ...
Vera Therapeutics has won FDA approval for Trutakna, a BAFF/APRIL inhibitor for IgA nephropathy (IgAN) that will compete with ...
Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...
“We went from 1 micro drama a day in July 2025 to five a day (150+ a month today). In terms of overall growth, we have grown ...
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovation in immuno-dermatology, today announced that Christopher “Chris” ...
USA News Group News Commentary - The most valuable real estate in medicine right now is a living cell. Across diabetes, organ transplant, and the fast-emerging field of longevity biology, developers ...
Auto Express on MSNOpinion
The future of the car is still bright and the Goodwood Festival of Speed proves it
Ryan Birch thinks the car industry will rise to its current challenges and Goodwood FoS proves it.
Pender Growth Fund Inc. (the "Company" or "PTF") is pleased to report that, further to the January 22, 2026 announcement of the proposed business combination (the "Business Combination") of long-time ...
When you send a prompt to an AI provider, something happens to that text before the response arrives. Most providers store it ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) for VX-264, a stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results